We are live on ! Find out more
BMO

Beck Mack & Oliver Portfolio holdings

AUM $5.13B
1-Year Est. Return 11.51%
This Fund
S&P 500
This Quarter Est. Return
+6.05%
1 Year Est. Return
+11.51%
3 Year Est. Return
+68.19%
5 Year Est. Return
+90.4%
10 Year Est. Return
+384.43%
AUM
$2.85B
AUM Growth
+$49.7M
Cap. Flow
-$75.2M
Cap. Flow %
-2.64%
Top 10 Hldgs %
41.46%
Holding
236
New
11
Increased
27
Reduced
106
Closed
12

Top Buys

Rank Stock Value
1
LUMN icon
Lumen
LUMN
+$11.8M
2
CACC icon
Credit Acceptance
CACC
+$5.56M
3
RDNT icon
RadNet
RDNT
+$4.84M
4
EPD icon
Enterprise Products Partners
EPD
+$3.54M
5
WAB icon
Wabtec
WAB
+$2.7M

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$28.9M
2
QCOM icon
Qualcomm
QCOM
+$10M
3
DOV icon
Dover
DOV
+$6.22M
4
ABT icon
Abbott
ABT
+$3.3M
5
BX icon
Blackstone
BX
+$2.94M

Sector Composition

Rank Sector Weight
1 Financials 30.92%
2 Healthcare 16.7%
3 Technology 13.21%
4 Communication Services 10.46%
5 Industrials 9.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DISCK
26
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$39.1M 1.37%
1,374,716
+5,900
+0.4% +$160K
UNP icon
27
Union Pacific
UNP
$169B
$39M 1.37%
230,374
-4,210
-2% -$721K
BN icon
28
Brookfield
BN
$82.9B
$34.4M 1.21%
2,017,401
-42,218
-2% -$714K
DOV icon
29
Dover
DOV
$25.5B
$28.5M 1%
284,332
-64,842
-19% -$6.22M
BB icon
30
BlackBerry
BB
$4.57B
$27.2M 0.96%
3,648,980
+173,564
+5% +$1.51M
GRFS
31
Grifois
GRFS
$5.01B
$25.6M 0.9%
1,213,151
-33,034
-3% -$630K
GILD icon
32
Gilead Sciences
GILD
$181B
$24.7M 0.87%
364,990
-4,521
-1% -$297K
WMS icon
33
Advanced Drainage Systems
WMS
$9.59B
$24.5M 0.86%
745,942
+15,517
+2% +$448K
LOW icon
34
Lowe's Companies
LOW
$109B
$24.2M 0.85%
239,740
-10,646
-4% -$1.12M
VZ icon
35
Verizon
VZ
$214B
$21.2M 0.75%
371,544
-8,272
-2% -$477K
JEF icon
36
Jefferies Financial Group
JEF
$11.3B
$20.5M 0.72%
1,191,442
-38,304
-3% -$657K
USB icon
37
US Bancorp
USB
$96.9B
$19M 0.67%
363,341
-3,873
-1% -$200K
MRK icon
38
Merck
MRK
$355B
$18.4M 0.65%
230,171
-3,511
-2% -$269K
ENB icon
39
Enbridge
ENB
$106B
$17.6M 0.62%
488,201
-10,210
-2% -$372K
TEVA icon
40
Teva Pharmaceuticals
TEVA
$45.7B
$16.3M 0.57%
1,767,777
-2,398,062
-58% -$28.9M
SYY icon
41
Sysco
SYY
$38.1B
$16.2M 0.57%
229,398
-8,740
-4% -$622K
WMT icon
42
Walmart Inc
WMT
$858B
$15.9M 0.56%
432,306
-14,850
-3% -$512K
WMB icon
43
Williams Companies
WMB
$87.6B
$15.3M 0.54%
545,918
-8,900
-2% -$247K
RDNT icon
44
RadNet
RDNT
$6.07B
$14.7M 0.52%
1,065,134
+376,981
+55% +$4.84M
DUK icon
45
Duke Energy
DUK
$91.8B
$14.6M 0.51%
165,509
-4,722
-3% -$417K
FDX icon
46
FedEx
FDX
$73B
$14.6M 0.51%
88,691
-2,272
-2% -$398K
XOM icon
47
ExxonMobil
XOM
$696B
$13.1M 0.46%
171,419
-14,832
-8% -$1.15M
NTR icon
48
Nutrien
NTR
$37.6B
$11.7M 0.41%
218,994
-2,700
-1% -$141K
MTB icon
49
M&T Bank
MTB
$34B
$10.9M 0.38%
64,177
-2,502
-4% -$415K
HUBB icon
50
Hubbell
HUBB
$23.2B
$10.7M 0.38%
81,859
-1,940
-2% -$239K
1
2
3 4 5

Similar funds

ACM
AKRE Capital Management Middleburg, Virginia $5.12B AUM 19.08% 1-Year Est. Return
BPCE
Bank Pictet & Cie (Europe) Frankfurt Am Main, Germany $5.12B AUM 27.39% 1-Year Est. Return
SGM
Skye Global Management West Palm Beach, Florida $5.14B AUM 6.88% 1-Year Est. Return
CFO
Callan Family Office Radnor, Pennsylvania $5.11B AUM 35.28% 1-Year Est. Return
SB
SIG Brokerage New York $5.15B AUM 78.53% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
MRCP
Maple Rock Capital Partners Toronto, Ontario, Canada $5.1B AUM 214.22% 1-Year Est. Return
KACA
Kayne Anderson Capital Advisors Los Angeles, California $5.1B AUM 17.16% 1-Year Est. Return

Beck Mack & Oliver's Q2 2019 Portfolio in Review

As of Q2 2019, Beck Mack & Oliver held 236 positions worth $2.85B, up 1.8% from $2.8B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Beck Mack & Oliver's Q2 2019 filing shows 11 new, 27 increased, 106 reduced and 12 closed positions. Its largest new stake was Focus Financial Partners Inc. Class A: 31,150 shares worth $851K. The largest sale was Teva Pharmaceuticals, an estimated $28.9M.

By sector, the portfolio is most concentrated in Financials at 31% of assets, up from 29% a quarter earlier, followed by Healthcare and Technology.

  • Beck Mack & Oliver's largest Q2 2019 buy was Focus Financial Partners Inc. Class A: 31,150 shares worth $851K.
  • Beck Mack & Oliver added most to Lumen in Q2 2019, an estimated $11.8M increase.
  • Beck Mack & Oliver's biggest Q2 2019 reduction was Teva Pharmaceuticals, cutting an estimated $28.9M.
  • Beck Mack & Oliver fully exited Unilever NV New York Registry Shares in Q2 2019, selling an estimated $656K.
  • Beck Mack & Oliver's ten largest holdings make up 41% of its $2.85B portfolio in Q2 2019.
  • Beck Mack & Oliver opened 11 new positions and closed 12 in Q2 2019.
  • Beck Mack & Oliver's portfolio value rose 1.8% quarter-over-quarter to $2.85B.

Based on Beck Mack & Oliver's 13F filing for Q2 2019, filed 13 Aug 2019.